Holen Sie sich die Stockscreener-App
18.16
5.78%
0.865
Schlusskurs vom Vortag:
$17.29
Offen:
$17.4
24-Stunden-Volumen:
108.06K
Relative Volume:
0.61
Marktkapitalisierung:
$1.12B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-46.13M
KGV:
-22.35
EPS:
-0.8123
Netto-Cashflow:
$-34.10M
1W Leistung:
+7.40%
1M Leistung:
+13.89%
6M Leistung:
+3.74%
1J Leistung:
+167.01%
1-Tages-Spanne:
$17.40
$18.40
1-Wochen-Bereich:
$16.40
$18.40
52-Wochen-Spanne:
$6.595
$25.00
Pulse Biosciences Inc Stock (PLSE) Company Profile
Firmenname
Pulse Biosciences Inc
Sektor
Telefon
510-906-4600
Adresse
3957 POINT EDEN WAY, HAYWARD, CA
Vergleichen Sie PLSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLSE
Pulse Biosciences Inc
|
18.12 | 1.12B | 0 | -46.13M | -34.10M | -0.8123 |
|
ISRG
Intuitive Surgical Inc
|
476.71 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
198.94 | 57.39B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
93.24 | 45.22B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
213.46 | 31.43B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
79.44 | 15.88B | 3.90B | 392.30M | 288.10M | 1.95 |
Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-07-27 | Eingeleitet | Stephens | Overweight |
| 2021-03-11 | Eingeleitet | Maxim Group | Buy |
| 2021-01-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-12 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-02-14 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-02-25 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Pulse Biosciences Inc Aktie (PLSE) Neueste Nachrichten
Vanguard Group Inc. Purchases 150,506 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Corebridge Financial Inc. Cuts Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
20,000 Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) Bought by Norges Bank - Defense World
KLP Kapitalforvaltning AS Buys Shares of 2,500 Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences: Some Key Questions Remain Unanswered - Seeking Alpha
Pulse Biosciences at Needham Conference: Strategic Growth and Market Expansion - Investing.com UK
Pulse Biosciences: Interesting Product, But No Revenue Stream (NASDAQ:PLSE) - Seeking Alpha
When (PLSE) Moves Investors should Listen - news.stocktradersdaily.com
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Pulse Biosciences, Inc. Announces Closing of $30 Million Rights Offering - Business Wire
Pulse Biosciences (NASDAQ:PLSE) Upgraded to Sell at StockNews.com - Defense World
PULSE BIOSCIENCES, INC. SEC 10-K Report - TradingView
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2024 Earnings Call Transcript - MSN
Pulse Biosciences (NASDAQ:PLSE) Shares Gap Up – What’s Next? - Defense World
Pulse Biosciences Insiders Placed Bullish Bets Worth US$2.79m - simplywall.st
Pulse Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Pulse Biosciences Inc Reports Q4 2024 GAAP Net Loss of $19.4 Mil - GuruFocus
Pulse Biosciences Reports Business Updates and Third Quarter 2024 Financial Results - TradingView
Charles Schwab Investment Management Inc. Grows Position in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs - Yahoo Finance
Pulse Biosciences Inc (PLSE) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Rising Costs By GuruFocus - Investing.com Canada
Earnings call transcript: Pulse Biosciences Q4 2024 misses EPS, stock rises - Investing.com Australia
Pulse Biosciences Inc. Reports 2024 Financial Results - TipRanks
Earnings call transcript: Pulse Biosciences Q4 2024 misses EPS, stock rises By Investing.com - Investing.com South Africa
Bank of New York Mellon Corp Has $676,000 Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences reports wider Q4 loss, shares dip By Investing.com - Investing.com South Africa
Pulse Biosciences reports wider Q4 loss, shares dip - Investing.com Australia
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results - Business Wire
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference - BioSpace
Breakthrough nsPFA Technology Updates Coming at Major Healthcare Conference - Stock Titan
AlphaQuest LLC Lowers Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Pulse Biosciences Announces Updated Timing of Rights Offering for Up to $60,000,000 - Business Wire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors With Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action – PLSE - Business Wire
(PLSE) Trading Advice - Stock Traders Daily
Oppenheimer & Co. Inc. Acquires New Shares in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
Oppenheimer & Co. Inc. Makes New $311,000 Investment in Pulse Biosciences, Inc. (NASDAQ:PLSE) - Armenian Reporter
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025 - Bluefield Daily Telegraph
When Will Pulse Biosciences Report Q4 Earnings? Key Date for nsPFA Technology Leader - StockTitan
Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Pulse Biosciences at TD Cowen Conference: nsPFA Technology Focus By Investing.com - Investing.com Canada
New York State Common Retirement Fund Sells 3,600 Shares of Pulse Biosciences, Inc. (NASDAQ:PLSE) - Defense World
(PLSE) Trading Signals - news.stocktradersdaily.com
Commit To Purchase Pulse Biosciences At $10, Earn 12.9% Annualized Using Options - Nasdaq
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Joplin Globe
MONDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Pulse Biosciences, Inc. with Losses of $100,000 to Contact the Firm - ACCESS Newswire
Investor Network: Pulse Biosciences, Inc. to Host Earnings Call - ACCESS Newswire
Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pulse Biosciences Inc-Aktie (PLSE) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| DUGGAN ROBERT W | Director |
Dec 13 '24 |
Buy |
17.18 |
55,256 |
949,298 |
42,328,717 |
| DUGGAN ROBERT W | Director |
Dec 12 '24 |
Buy |
17.13 |
45,404 |
777,771 |
42,273,461 |
| DUGGAN ROBERT W | Director |
Dec 11 '24 |
Buy |
17.35 |
56,054 |
972,344 |
42,228,057 |
| Barrett Burke Thomas | President and CEO |
May 20 '24 |
Buy |
8.56 |
10,000 |
85,600 |
10,000 |
1.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):